New Uses for Older Drugs: The Tales of Aspirin, Thalidomide, and Gabapentin

Sirven, Joseph I.
June 2010
Mayo Clinic Proceedings;Jun2010, Vol. 85 Issue 6, p508
Academic Journal
The article discusses various reports published within the issue including the research on gabapentin therapy, the beneficial effects of such drug in patients with chronic neurologic conditions, and the feature on the use of gabapentin via percutaneous endogastric tube for managing opsoclonus-myoclonus syndrome.


Related Articles

  • Preface. T. W. Rosahl; J. R. Atack // Current Drug Targets - CNS & Neurological Disorders;Aug2003, Vol. 2 Issue 4, p1 

    This hot topic issue of Current Drug Targets - CNS and Neurological Disorders focuses on the GABAergic system for the development of novel and improved therapeutic approaches. GABA (?-aminobutyric acid) is the major inhibitory neurotransmitter system in the mammalian brain and has been...

  • GABAB Receptors as Potential Therapeutic Targets. Claire-Marie Vacher; Bernhard Bettler // Current Drug Targets - CNS & Neurological Disorders;Aug2003, Vol. 2 Issue 4, p248 

    ?-Aminobutyric acid-B (GABAB) receptors are broadly expressed in the nervous system and have been implicated in a wide variety of neurological and psychiatric disorders. To date the only GABAB drug on the market is the agonist baclofen (Lioresal�) that is used to treat severe spasticity of...

  • Glutamic acid decarboxylase autoantibodies and neurological disorders. Vianello, M.; Tavolato, B.; Giometto, B. // Neurological Sciences;Oct2002, Vol. 23 Issue 4, p145 

    Suggests two mechanisms behind the potential pathogenic role of glutamic acid decarboxylase autoantibodies (GAD-Ab) in neurological disorders. Reduction by GAD-Ab of gamma-aminobutyric acid (GABA) synthesis in nerve terminals; Interference with exocytosis of GABA.

  • A Role of GABA Analogues in the Treatment of Neurological Diseases. Gajcy, K.; Lochynski, S.; Librowski, T. // Current Medicinal Chemistry;Aug2010, Vol. 17 Issue 22, p2338 

    ?-Amino butyric acid is an extremely important inhibitory neurotransmitter in the mammalian central nervous system and is essential for the overall balance between neuronal excitation and inhibition. It is well documented that GABA deficiency is associated with several important neurological...

  • Antiepileptics and the Treatment of Neuropathic Pain: Evidence from Animal Models. Blackburn-Munro, G.; Erichsen, H. K. // Current Pharmaceutical Design;Sep2005, Vol. 11 Issue 23, p2961 

    Neuropathic pain is characterised by both positive (hyperalgesia and allodynia) and negative (sensory deficits) symptoms and remains intractable to many commonly used analgesics. Antiepileptics are increasingly utilised in the treatment of neuropathic pain. This class of drugs works via three...

  • Transcriptional control of Gad2. Pan, Zhizhong Z. // Transcription (2154-1264);2012, Vol. 3 Issue 2, p68 

    The article discusses the advances in the regulatory mechanisms for Gad2 gene transcription. It highlights the characteristics of TATA-less Gad2 promoters and regulation of Gad2 transcription by CREB and by activity-dependent epigenetic modification of the chromatin structure in regulatory...

  • Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs. AndreasTurski, Christopher; Ikonomidou, Chrysanthy // Frontiers in Neurology;Aug2012, Vol. 3, p1 

    Glutamate (Glu) and g-aminobutyric acid (GABA) are major neurotransmitters in the mammalian brain which regulate brain development at molecular, cellular, and systems level. Sedative, anesthetic, and antiepileptic drugs (AEDs) interact with glutamate and GABA receptors to produce their desired...

  • GABAergic Neuronal Precursor Grafting: Implications in Brain Regeneration and Plasticity. Dolado, Manuel Alvarez; Broccoli, Vania // Neural Plasticity;2011, Vol. 2011, Special section p1 

    Numerous neurological disorders are caused by a dysfunction of the GABAergic system that impairs or either stimulates its inhibitory action over its neuronal targets. Pharmacological drugs have generally been proved very effective in restoring its normal function, but their lack of any sort of...

  • Association of antinociceptive action of botulinum toxin type A with GABA-A receptor. Drinovac, V.; Bach-Rojecky, L.; Lacković, Z. // Journal of Neural Transmission;Jun2014, Vol. 121 Issue 6, p665 

    The mechanism of botulinum toxin type A (BTX-A) antinociceptive action in the central nervous system is little known. The potential interaction between BTX-A and GABAergic system has not been investigated previously. In the present study, we demonstrate prevention of BTX-A antinociceptive effect...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics